BeOne Medicines
This role focuses on developing robust and scalable manufacturing platforms for allogeneic cell expansion and directed differentiation within a cGMP-regulated environment. The successful candidate will design and execute process development studies, establish manufacturing parameters, and contribute to regulatory filings for engineered immune cell therapies. The position requires collaboration with analytical development and R&D teams to ensure product safety, purity, and stability throughout all stages of development.
Headquarters
Cambridge, Massachusetts, United States
Company Size
1-10 employees
Founded
2010
BeOne Medicines, formerly BeiGene, is committed to advancing cancer care through a science‑led, purpose‑driven model that improves treatment access for patients worldwide.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for BeOne Medicines.
BeOne Medicines didn’t post a salary, so this is our estimate from similar listings.
9% below the average for this role
Spring Co-Op
Digital Biology
Postdoctoral Research Fellow
Mayo Clinic
Scientist I/II, In Vitro Pharmacology
Alloy Therapeutics
Postdoctoral Research Scientist
Columbia University
Senior Associate Scientist - Engineered Cell Therapy Discovery
Bristol Myers Squibb
Post-Doctoral Fellows - Veglia Lab
The Wistar Institute